Abstract:BackgroundRadiation-induced gastrointestinal syndrome (RIGS) results from the acute loss of intestinal stem cells (ISC), impaired epithelial regeneration, and subsequent loss of the mucosal barrier, resulting in electrolyte imbalance, diarrhea, weight loss, sepsis, and mortality. The high radiosensitivity of the intestinal epithelium limits effective radiotherapy against abdominal malignancies and limits the survival of victims of nuclear accidents or terrorism. Currently, there is no approved therapy to mitigate radiation toxicity in the intestine. Here we demonstrate that BCN057, an anti-neoplastic small molecular agent, induces ISC proliferation and promotes intestinal epithelial repair against radiation injury.MethodsBCN057 (90 mg/kg body weight, subcutaneously) was injected into C57Bl6 male mice (JAX) at 24 h following abdominal irradiation (AIR) and was continued for 8 days post-irradiation. BCN057-mediated rescue of Lgr5-positive ISC was validated in Lgr5-EGFP-Cre-ERT2 mice exposed to AIR. The regenerative response of Lgr5-positive ISC was examined by lineage tracing assay using Lgr5-EGFP-ires-CreERT2-TdT mice with tamoxifen administration to activate Cre recombinase and thereby marking the ISC and their respective progeny. Ex vivo three-dimensional organoid cultures were developed from surgical specimens of human colon or from mice jejunum and were used to examine the radio-mitigating role of BCN057 on ISC ex vivo. Organoid growth was determined by quantifying the budding crypt/total crypt ratio. Statistical analysis was performed using Log-rank (Mantel-Cox) test and paired two-tail t test.ResultsTreatment with BCN057 24 h after a lethal dose of AIR rescues ISC, promotes regeneration of the intestinal epithelium, and thereby mitigates RIGS. Irradiated mice without BCN057 treatment suffered from RIGS, resulting in 100% mortality within 15 days post-radiation. Intestinal organoids developed from mice jejunum or human colon demonstrated a regenerative response with BCN057 treatment and mitigated radiation toxicity. However, BCN057 did not deliver radio-protection to mouse or human colon tumor tissue.ConclusionBCN057 is a potential mitigator against RIGS and may be useful for improving the therapeutic ratio of abdominal radiotherapy. This is the first report demonstrating that a small molecular agent mitigates radiation-induced intestinal injury by inducing ISC self-renewal and proliferation.

CRX-527 induced differentiation of HSCs protecting the intestinal epithelium from radiation damage

The Protective Effects of XH‐105 Against Radiation‐induced Intestinal Injury

Toll-like Receptor Agonist CBLB502 Protects Against Radiation-induced Intestinal Injury in Mice

The Protective Effect of New Compound XH-103 on Radiation-Induced GI Syndrome

Phycocyanin Ameliorates Radiation-Induced Acute Intestinal Toxicity by Regulating the Effect of the Gut Microbiota on the TLR4/Myd88/NF-κB Pathway

CL429 enhances the renewal of intestinal stem cells by upregulating TLR2-YAP1

Co-Activation of PKC-δ by CRIF1 Modulates Oxidative Stress in Bone Marrow Multipotent Mesenchymal Stromal Cells after Irradiation by Phosphorylating NRF2 Ser40.

CXCR2 Is Essential for Radiation-Induced Intestinal Injury by Initiating Neutrophil Infiltration

CCR2-driven monocyte recruitment is protective against radiotherapy-induced intestinal toxicity

Transient HR enhancement by RAD51-stimulatory compound confers protection on intestinal rather than hematopoietic tissue against irradiation in mice

The Protective Effects of SB203580 Against Mortality and Radiation Induced Intestinal Injury of Mice

Mesenchymal Stem Cells Over-Expressing Cxcl12 Enhance the Radioresistance of the Small Intestine.

Regulation of the regeneration of intestinal stem cells after irradiation

BCN057 induces intestinal stem cell repair and mitigates radiation-induced intestinal injury

Role of gene-modified bone marrow mesenchymal stem cells in repair of radiation-induced intestinal injury

Human mesenchymal stem cells promote survival and prevent intestinal damage in a mouse model of radiation injury

SIRT1 inhibitors mitigate radiation-induced GI syndrome by enhancing intestinal-stem-cell survival

Single-cell RNA sequencing of intestinal crypts reveals vital events in damage repair and the double-edged sword effect of the Wnt3/β-catenin pathway in irradiated mice

The GS-nitroxide JP4-039 improves intestinal barrier and stem cell recovery in irradiated mice

Directional delivery of RSPO1 by mesenchymal stem cells ameliorates radiation-induced intestinal injury

REGγ Drives Lgr5 + Stem Cells to Potentiate Radiation Induced Intestinal Regeneration